Driving Global Discovery in Endoscopy at DDW 2026: Concemed's Advanced Endoscopy Solutions
[Chicago], [May 2-5] — Concemed, a leading innovator in flexible endoscopy solutions, is proud to announce the successful conclusion of its participation at Digestive Disease Week (DDW) 2026. Held in a dynamic hybrid format, this year’s event was a resounding success, attracting a total of 14,352 participants from across the globe—including 13,392 on-site attendees and 960 joining virtually.
Embracing "Discovery at Every Turn"
Aligned with the DDW 2026 theme, "Discovery at Every Turn," the Concemed exhibit focused on empowering clinicians to detect the undetectable. Our live product demonstrations highlighted the V1000 system's superior maneuverability and imaging precision, attracting significant attention from the international gastroenterology community.

Technical Highlights: Beyond Traditional Imaging
The V1000 system received exceptional acclaim for its ability to bridge the gap between routine examination and advanced therapeutic intervention:
● High-Fidelity Visualization: Our high-definition White Light Imaging (WLI) was praised for its high color rendering index. By displaying accurate tissue color, the system enables more confident and precise diagnoses.
● Comprehensive Spectral Intelligence: The V1000 is fully equipped with advanced spectral imaging modes—DSI, TEI, PSI, and HEI. These tools expand clinical applications from standard screenings to providing detailed diagnostic information and guidance during complex treatments.
● Micron-level Precision: While magnifying endoscopes are an industry staple, the Concemed magnification technology was a standout innovation. By combining 145x magnification with DSI technology, our system reveals stunning micron-level images of micro-structures and micro-vessels.
● Accessible Early Detection: With the integration of One-click Autofocus, the detection of minimal lesions is now more accessible to all endoscopists, significantly lowering the barrier for early-stage cancer diagnosis.
Global Reach and Regional Penetration
● The event served as a hub for global coverage and regional deep penetration. We engaged with experts and distributors from over eight countries across North America, LATAM, and EMEA.
● A particularly notable outcome was the high volume of inquiries regarding our roadmap for the North American market. The strong demand from international endoscopists and partners provides a clear signal of our system's competitive excellence and our exciting path toward global expansion.

A Shared Success
"The incredible reception of the V1000 at DDW 2026 reinforces our commitment to clinical practicality and ergonomic engineering," said a representative from Concemed. "The success of this event would not have been possible without the support of our dedicated partners. We look forward to building on this momentum and driving the business to new heights."






